The cell painting assay is a high-content, high-throughput imaging technique used to capture a wide array of cellular phenotypes in response to diverse perturbations. These phenotypes, often termed "morphological profiles", can be used to understand various biological phenomena, including cellular responses to genetic changes, drug treatments, and other environmental changes. This has been adopted by many pharmaceutical companies in profiling compounds, including Recursion Pharmaceuticals, Bayer, and AstraZeneca